268 related articles for article (PubMed ID: 15745752)
1. A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds.
Ncokazi KK; Egan TJ
Anal Biochem; 2005 Mar; 338(2):306-19. PubMed ID: 15745752
[TBL] [Abstract][Full Text] [Related]
2. Simple colorimetric inhibition assay of heme crystallization for high-throughput screening of antimalarial compounds.
Huy NT; Uyen DT; Maeda A; Trang DT; Oida T; Harada S; Kamei K
Antimicrob Agents Chemother; 2007 Jan; 51(1):350-3. PubMed ID: 17088494
[TBL] [Abstract][Full Text] [Related]
3. Quinoline antimalarials decrease the rate of beta-hematin formation.
Egan TJ; Ncokazi KK
J Inorg Biochem; 2005 Jul; 99(7):1532-9. PubMed ID: 15927260
[TBL] [Abstract][Full Text] [Related]
4. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs.
Parapini S; Basilico N; Pasini E; Egan TJ; Olliaro P; Taramelli D; Monti D
Exp Parasitol; 2000 Dec; 96(4):249-56. PubMed ID: 11162378
[TBL] [Abstract][Full Text] [Related]
5. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update.
Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U
Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328
[TBL] [Abstract][Full Text] [Related]
6. [Comparative observation on inhibition of hemozoin formation and their in vitro and in vivo anti-schistosome activity displayed by 7 antimalarial drugs].
Xue J; Jiang B; Liu CS; Sun J; Xiao SH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):161-9. PubMed ID: 24812850
[TBL] [Abstract][Full Text] [Related]
7. Experimental conditions for testing the inhibitory activity of chloroquine on the formation of beta-hematin.
Baelmans R; Deharo E; Muñoz V; Sauvain M; Ginsburg H
Exp Parasitol; 2000 Dec; 96(4):243-8. PubMed ID: 11162377
[TBL] [Abstract][Full Text] [Related]
8. Inhibition assay of beta-hematin formation initiated by lecithin for screening new antimalarial drugs.
Trang DT; Huy NT; Uyen DT; Sasai M; Shiono T; Harada S; Kamei K
Anal Biochem; 2006 Feb; 349(2):292-6. PubMed ID: 16376288
[TBL] [Abstract][Full Text] [Related]
9. Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity.
Biot C; Taramelli D; Forfar-Bares I; Maciejewski LA; Boyce M; Nowogrocki G; Brocard JS; Basilico N; Olliaro P; Egan TJ
Mol Pharm; 2005; 2(3):185-93. PubMed ID: 15934779
[TBL] [Abstract][Full Text] [Related]
10. Screening medicinal plants for the detection of novel antimalarial products applying the inhibition of β-hematin formation.
Vargas S; Ndjoko Ioset K; Hay AE; Ioset JR; Wittlin S; Hostettmann K
J Pharm Biomed Anal; 2011 Dec; 56(5):880-6. PubMed ID: 21872416
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial versus cytotoxic properties of dual drugs derived from 4-aminoquinolines and Mannich bases: interaction with DNA.
Wenzel NI; Chavain N; Wang Y; Friebolin W; Maes L; Pradines B; Lanzer M; Yardley V; Brun R; Herold-Mende C; Biot C; Tóth K; Davioud-Charvet E
J Med Chem; 2010 Apr; 53(8):3214-26. PubMed ID: 20329733
[TBL] [Abstract][Full Text] [Related]
12. Identification of β-hematin inhibitors in the MMV Malaria Box.
Fong KY; Sandlin RD; Wright DW
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):84-91. PubMed ID: 26150923
[TBL] [Abstract][Full Text] [Related]
13. Alcohols induce beta-hematin formation via the dissociation of aggregated heme and reduction in interfacial tension of the solution.
Huy NT; Maeda A; Uyen DT; Trang DT; Sasai M; Shiono T; Oida T; Harada S; Kamei K
Acta Trop; 2007 Feb; 101(2):130-8. PubMed ID: 17274939
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of some cryptolepine analogues, assessment of their antimalarial and cytotoxic activities, and consideration of their antimalarial mode of action.
Onyeibor O; Croft SL; Dodson HI; Feiz-Haddad M; Kendrick H; Millington NJ; Parapini S; Phillips RM; Seville S; Shnyder SD; Taramelli D; Wright CW
J Med Chem; 2005 Apr; 48(7):2701-9. PubMed ID: 15801861
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimalarial activity of side chain modified 4-aminoquinoline derivatives.
Solomon VR; Haq W; Srivastava K; Puri SK; Katti SB
J Med Chem; 2007 Jan; 50(2):394-8. PubMed ID: 17228883
[TBL] [Abstract][Full Text] [Related]
16. In situ localization and structural analysis of the malaria pigment hemozoin.
Frosch T; Koncarevic S; Zedler L; Schmitt M; Schenzel K; Becker K; Popp J
J Phys Chem B; 2007 Sep; 111(37):11047-56. PubMed ID: 17718555
[TBL] [Abstract][Full Text] [Related]
17. In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials.
Tripathi AK; Gupta A; Garg SK; Tekwani BL
Life Sci; 2001 Oct; 69(23):2725-33. PubMed ID: 11720077
[TBL] [Abstract][Full Text] [Related]
18. B-hematin.
Blauer G; Akkawi M
Biochem Mol Biol Int; 1995 Feb; 35(2):231-5. PubMed ID: 7663376
[TBL] [Abstract][Full Text] [Related]
19. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization.
Sandlin RD; Carter MD; Lee PJ; Auschwitz JM; Leed SE; Johnson JD; Wright DW
Antimicrob Agents Chemother; 2011 Jul; 55(7):3363-9. PubMed ID: 21518844
[TBL] [Abstract][Full Text] [Related]
20. Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay.
Tekwani BL; Walker LA
Comb Chem High Throughput Screen; 2005 Feb; 8(1):63-79. PubMed ID: 15720198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
